Healthcare Services

Aortic Stenosis Market Revenue Expected to Reach $16.16 Billion by 2030 with 12.6% CAGR

March 30, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Much Is The Aortic Stenosis Market Expected To Grow In Terms Of Market Value Between 2026 And 2030?

The aortic stenosis market size has experienced rapid expansion in recent years. Its value is anticipated to rise from $8.91 billion in 2025 to $10.06 billion in 2026, achieving a compound annual growth rate (CAGR) of 12.9%. The drivers for this historical growth include an aging global population, the increasing incidence of degenerative heart valve diseases, the expansion of cardiac catheterization labs, enhancements in surgical valve replacement techniques, and growing clinical awareness of valvular disorders.

The aortic stenosis market is projected to experience significant expansion over the coming years, with its size expected to reach $16.17 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.6%. This anticipated growth during the forecast period is primarily driven by factors such as increasing investments in next-generation valve technologies, the rising adoption of tavr procedures, the expansion of outpatient cardiac care models, a growing focus on early intervention strategies, and the increasing integration of digital cardiac monitoring tools. Furthermore, major trends observed within this period include the increasing adoption of transcatheter valve replacement procedures, a rising demand for minimally invasive cardiac interventions, the growing use of advanced diagnostic imaging, the expansion of personalized valve therapy solutions, and an enhanced focus on early disease detection.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21102&type=smp

What Key Drivers Are Influencing The Growth Of The Aortic Stenosis Market?

The escalating incidence of heart ailments is anticipated to fuel the expansion of the aortic stenosis market in the foreseeable future. Heart diseases represent a spectrum of conditions that impact the heart’s structural integrity and functional performance. These disorders can hinder the heart’s capacity to efficiently pump blood, thereby leading to various complications. Notable heart diseases include coronary artery disease (CAD), heart failure, arrhythmias, valvular heart disease, and cardiomyopathy, among others. Aortic stenosis specifically involves the narrowing of the aortic valve, which impedes the flow of blood from the left ventricle to the aorta. This elevated resistance compels the heart to work harder, potentially resulting in heart failure and other cardiovascular complications over time. Effective treatment for aortic stenosis, such as valve replacement or TAVI, contributes to improved cardiac function and reduces the risk of severe outcomes from heart disease. For instance, in January 2025, the British Heart Foundation, a UK-based cardiovascular research charity, reported that approximately 7.6 million people in the UK are living with heart and circulatory diseases, including around 4 million males and 3.6 million females. These conditions are attributed to about 27% of all deaths in the UK, causing over 170,000 fatalities annually, which equates to 480 deaths per day. Hence, the growing prevalence of heart diseases is a significant driver for the growth of the aortic stenosis market.

What Major Segment Divisions Exist Within The Aortic Stenosis Market?

The aortic stenosis market covered in this report is segmented –

1) By Type: Congenital Aortic Stenosis, Acquired Aortic Stenosis

2) By Treatment: Surgical Aortic Valve Replacement, Transcatheter Aortic Valve Replacement, Balloon Aortic Valvuloplasty

3) By End User: Hospitals and Cardiac Centers, Ambulatory Surgical Centers, Cardiac Surgeons and Interventional Cardiologists

Subsegments:

1) By Congenital Aortic Stenosis: Neonatal Aortic Stenosis, Infantile Aortic Stenosis, Juvenile Aortic Stenosis

2) By Acquired Aortic Stenosis: Age-Related Aortic Stenosis, Degenerative Aortic Stenosis, Rheumatic Aortic Stenosis

Which Market Trends Are Creating New Opportunities In The Aortic Stenosis Market?

Leading companies operating within the aortic stenosis market are prioritizing the development of innovative aortic valve technologies, including transcatheter aortic valve implantation (TAVI) systems. This effort aims to improve patient outcomes, mitigate procedural risks, and enhance the overall effectiveness of aortic treatment. The transcatheter aortic valve implantation (TAVI) system functions as a minimally invasive medical device, facilitating the replacement of a compromised aortic valve without the need for open-heart surgery. As an example, in January 2023, Abbott Laboratories, a US-based medical device company, obtained approval from the U.S. Food and Drug Administration (FDA) for Navitor, their latest-generation transcatheter aortic valve implantation (TAVI) system. Navitor is characterized by its NaviSeal fabric cuff, engineered to minimize or eliminate paravalvular leaks. Furthermore, the system’s design, which places leaflets within the native valve, is intended to improve accessibility to coronary arteries for future interventions related to coronary artery disease.

Which Companies Are Leading Innovation In The Aortic Stenosis Market?

Major companies operating in the aortic stenosis market are Abbott Laboratories, Medtronic plc, Edwards Lifesciences Corporation, Boston Scientific Corporation, Terumo Corporation, LivaNova PLC, CryoLife Inc, Anteris Technologies Ltd, Venus Medtech, Peijia Medical, MicroPort Scientific Corporation, Lepu Medical Technology Co Ltd, Symetis SA, Artivion Inc, HighLife SAS, Transcatheter Technologies GmbH, NaviGate Cardiac Structures Inc, Xeltis BV, Sorin Group, Meril Life Sciences Pvt Ltd, On-X Life Technologies Inc, Braile Biomédica, Colibri Heart Valve

Read the full aortic stenosis market report here:

https://www.thebusinessresearchcompany.com/report/aortic-stenosis-global-market-report

Which Region Is Expected To Register The Fastest Growth In The Aortic Stenosis Market?

North America was the largest region in the aortic stenosis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the aortic stenosis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Aortic Stenosis Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=21102&type=smp

Browse Through More Reports Similar to the Global Aortic Stenosis Market 2026, By The Business Research Company

Aortic Aneurysm Global Market Report

https://www.thebusinessresearchcompany.com/report/aortic-aneurysm-global-market-report

Aortic Endograft Global Market Report

https://www.thebusinessresearchcompany.com/report/aortic-endograft-global-market-report

Vascular Stent Global Market Report

https://www.thebusinessresearchcompany.com/report/vascular-stent-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795